Published in

Elsevier, Value in Health, 7(18), p. A442, 2015

DOI: 10.1016/j.jval.2015.09.1090

Links

Tools

Export citation

Search in Google Scholar

Pharmacoeconomic Analysis of the use of Everolimus Compared to Axitinib in Second Line Therapy of Patients with Metastatic Renal Cell Carcinoma

Journal article published in 2015 by A. Kolbin ORCID, Maxim Frolov ORCID, A. Kurylev ORCID, Y. Balykina, M. Proskurin
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO